Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01288430
What this trial is testing

DS-2248 in Participants With Advanced Solid Tumors

Who this might be right for
Solid TumorsNon-small Cell Lung Carcinoma
Daiichi Sankyo 60
Not applicableEnded earlyNCT02079181
What this trial is testing

18F-FMAU PET/CT in Imaging Patients With Advanced Cancers

Who this might be right for
Malignant Neoplasm
University of Southern California 3
Early research (Phase 1)Active Not RecruitingNCT05853367
What this trial is testing

Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001)

Who this might be right for
Metastatic Solid TumorsAdvanced Solid Tumors
Merck Sharp & Dohme LLC 95
Testing effectiveness (Phase 2)Study completedNCT03977467
What this trial is testing

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

Who this might be right for
Non-Small Cell Lung CancerSolid Tumor
SCRI Development Innovations, LLC 46
Early research (Phase 1)Study completedNCT00085553
What this trial is testing

Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors

Who this might be right for
Solid Neoplasm
National Cancer Institute (NCI) 29
Large-scale testing (Phase 3)WithdrawnNCT04065165
What this trial is testing

Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome

Who this might be right for
Small Intestinal NETCarcinoid Heart Disease
European Organisation for Research and Treatment of Cancer - EORTC
Early research (Phase 1)Study completedNCT00782002
What this trial is testing

Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 27
Early research (Phase 1)Looking for participantsNCT06907628
What this trial is testing

A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06081907
What this trial is testing

The Efficacy and Safety of IBI363 in Solid Tumors

Who this might be right for
Advanced Solid Tumor
Hunan Province Tumor Hospital 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT05199272
What this trial is testing

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

Who this might be right for
Solid TumorClear Cell Renal Cell CarcinomaEpithelial Ovarian Cancer+6 more
23andMe, Inc. 141
Early research (Phase 1)Study completedNCT00980239
What this trial is testing

HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver

Who this might be right for
Liver CancerAdvanced Cancer
M.D. Anderson Cancer Center 115
Testing effectiveness (Phase 2)Active Not RecruitingNCT05853575
What this trial is testing

Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)

Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplasm of Lung
Mirati Therapeutics Inc. 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05888857
What this trial is testing

MEDI5752 in Patients With Mature Tertiary Lymphoid Structures Solid Tumors.

Who this might be right for
Advanced Solid Tumor
Institut Bergonié 102
Testing effectiveness (Phase 2)Ended earlyNCT02100007
What this trial is testing

ME-344 Given in Combination With Hycamtin® in Patients With Solid Tumors

Who this might be right for
Solid Tumors
MEI Pharma, Inc. 46
Early research (Phase 1)Ended earlyNCT02620839
What this trial is testing

Phase Ib Study of Alpelisib With Cisplatin in Patients With HPV+ Solid Tumor Malignancies

Who this might be right for
Solid Tumors
Pamela Munster 28
Early research (Phase 1)Study completedNCT01011972
What this trial is testing

Intravenous XMT-1107 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasm Metastasis
Mersana Therapeutics 52
Early research (Phase 1)Looking for participantsNCT06307795
What this trial is testing

Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Avistone Biotechnology Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT00600275
What this trial is testing

A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer

Who this might be right for
Solid TumorsBreast CancerCowden Syndrome
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06704828
What this trial is testing

A Phase II Study of SHR-4602 as Montherapy or in Combination With Other Anti-tumor Therapies in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Study completedNCT02583165
What this trial is testing

A Study in Adult Subjects With Select Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
MedImmune LLC 40
Next Page